Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00812552 · ClinicalTrials.gov registry record

Drug Eluting Stent Registry of Thrombosis

A clinical trial of Coronary Artery Disease, sponsored by Medstar Health Research Institute.

Completed
Registry status
984
Enrollment target
20
Study locations

NCT00812552: Completed study of Coronary Artery Disease, sponsored by Medstar Health Research Institute.

NCT00812552 is a study of Coronary Artery Disease that has completed, run by Medstar Health Research Institute. The registered enrollment target is 984 participants, below the 1,282-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (23% lower). The trial reports 20 study locations across 18 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00812552, a study of Coronary Artery Disease, has completed, sponsored by Medstar Health Research Institute.

COMPLETED
Registry status
984 participants
Enrollment target
20
Study locations

Study Summary

Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.

Conditions Studied

Study Locations (20)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston
  • Lahey Clinic - Burlington

New York

  • New York Methodist Hospital - Brooklyn
  • Columbia University Medical Center - New York

California

  • Mercy General Hospital / Mercy Heart and Vascular Institute Cardiovascular Research - Sacramento

District of Columbia

  • Washington Hospital Center - Washington D.C.

Illinois

  • Prairie Education and Research Cooperative - Springfield

Kentucky

  • Lexington Cardiac Research Foundation/Central Baptist Hospital - Lexington

Maine

  • Maine Medical Center - Portland

Maryland

  • Washington Adventist Hospital - Takoma Park

Trial Details

FieldValue
Enrollment Target 984 participants
Start Date 2009-09
Est. Completion 2012-05
Medstar Health Research Institute

115 total trials

What the finished NCT00812552 record still lists

NCT00812552 is an observational study that tracks outcomes without assigning an intervention. The registered 984 participants enrollment target is mid-sized for trials with a published cap, below the 1,282-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (23% lower).

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00812552 names 20 study sites across 18 states, led by Massachusetts, New York, California.

Frequently Asked Questions

What is clinical trial NCT00812552 about?

NCT00812552 is a clinical study titled "Drug Eluting Stent Registry of Thrombosis". Multicenter, case-control study, to collect data regarding incidences of late and very late drug-eluting stent thrombosis with the aim of identifying trends and possible correlates of stent thrombosis.

What is the current status of trial NCT00812552?

This trial is currently completed. The enrollment target is 984 participants. The study started on 2009-09. Estimated completion is 2012-05.

What conditions does trial NCT00812552 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT00812552?

This trial is sponsored by Medstar Health Research Institute, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00812552 being conducted?

This trial has 20 study locations across California, District of Columbia, Illinois, Kentucky, Maine. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00812552's enrollment target sits among peer trials

984 50th of 219 higher than 170 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06989437 · 982 participants · Phase 2

    A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

  • NCT06959095 · 981 participants · Phase 3

    Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)

  • NCT05079841 · 988 participants · Phase 4

    The Stimulation To Induce Mothers Study

  • NCT06337097 · 980 participants · NA

    STRICT - Surveillance With TRoponin During Immune Checkpoint Therapy

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00812552, the US trial registry maintained by the National Library of Medicine. NCT00812552 (mid enrollment · wide site footprint · completed) retrieved and formatted by PlainTrial, see methodology.